Fed. Circ. OKs Teva's Patent Win Over Allergan Colitis Drug
Teva Pharmaceuticals USA Inc. scored a win on Wednesday when the Federal Circuit affirmed an Eastern District of Texas ruling that the generics maker did not infringe Allergan USA's patent for...To view the full article, register now.
Already a subscriber? Click here to view full article